Accuray Inc (NQ: ARAY )
4.980 USD -0.180 (-3.49%) Official Closing Price Updated: 4:34 PM EST, Feb 26, 2021 Add to My Watchlist
Press releases about Accuray Inc
Accuray Generated $55.6 Million in First Quarter Gross Orders; Revenue Increased 5 Percent Year over Year
October 24, 2017
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first fiscal quarter ended September 30, 2017.
European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy® System
October 19, 2017
Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy® System...
Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2017 on Tuesday, October 24, 2017 after the market close. Management will host a conference call to...
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, an equity inducement award to Shig Hamamatsu, the company's new VP, Finance & Chief Accounting Officer. As...
Today's Research Report Coverage on Medical Equipment Stocks -- CHF Solutions, ReWalk Robotics, Lantheus, and Accuray
September 26, 2017
10-year Data Shows CyberKnife® System Provides Excellent Long-term Control of Low-Risk Prostate Cancer
September 26, 2017
First Study to Evaluate the Use of Stereotactic Body Radiation Therapy in Low-Risk Prostate Cancer 10 Years Post Treatment
Accuray Showcases CyberKnife® and Radixact™ Systems at ASTRO 2017
September 20, 2017
Accuray Incorporated (NASDAQ: ARAY) announced today that data and first-hand experience with its advanced CyberKnife® and Radixact™ Systems, and unique software solutions, will be shared by leading...
Accuray Reports Fourth Quarter and Fiscal 2017 Financial Results
August 22, 2017
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2017.
Medical Equipment Stocks on Investors' Radar -- Steris, Accuray, NuVasive, and NovoCure
August 21, 2017
Summit Cancer Center-Boise Treats Its First Cancer Patients Using the Accuray Radixact™ System
August 17, 2017
Freestanding Center is First in the Western U.S. to Treat Patients with this "Smart" Radiation Therapy Delivery System with Fully-Integrated Treatment Planning and Data Management Systems
Accuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017
August 14, 2017
Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2017 ended June 30, 2017 on Tuesday, August 22, 2017 after the market close. Management will host a...
First Radixact™ System Research Results Presented at the American Association of Physicists in Medicine Annual Meeting
August 04, 2017
Accuray Incorporated (NASDAQ: ARAY) announced today that the first studies validating the benefits of the leading-edge Radixact™ System were presented at the 59th Annual Meeting of the American...
Accuray Receives 510(k) Clearance for iDMS™ Data Management System Upgrade for the TomoTherapy® System
July 31, 2017
iDMS System Allows Seamless Integration between Accuray Radixact™, TomoTherapy® and CyberKnife® Systems and Treatment Planning Systems
New Data Show TomoTherapy® System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
July 20, 2017
Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly Better Cancer-Specific...
Q4 Revenue Expected to be Approximately $111.5-$112 Million and Q4 Gross Orders Expected to be Approximately $86 Million; Accuray Expects to Finish Fiscal Year with Approximately $108 Million in Cash,...
Leading Hospital will be the First in the Middle East to Offer Patients Precise Treatments with the Latest Generations of Both Systems
Montefiore is First in NY Metropolitan Area to Treat Cancer Patients with Accuray Radixact™ System
June 27, 2017
Cutting-Edge Radiation Therapy System Dramatically Improves Precision, Efficiency and Safety, While Minimizing Side Effects
The French Cancer Institute is Building its Re-irradiation and Adaptive Radiotherapy Program Using the Latest Technology Developed by Accuray
Anova Marks 1,500th Prostate Cancer Patient Treated with the Accuray CyberKnife® System
June 16, 2017
Accuray Enters into New Revolving Loan Agreement
June 15, 2017
Today's Research Report Coverage on Medical Equipment Stocks -- Neovasc, NuVasive, Amedica, and Accuray
June 12, 2017
Accuray Appoints Stan Gee VP of Revenue Management
May 24, 2017
Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed, Stan Gee, who has been with Accuray for over eight years, to the newly created Vice President of Revenue Management position...
New Data Reinforce Benefits of TomoTherapy® Platform for Mainstream Radiation Therapy Treatment Indications
May 11, 2017
Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control withReduced Toxicities
New Data Presented at ESTRO 36 Reinforce Unmatched Versatility and Precision of the CyberKnife® System
May 11, 2017
Studies Show the System Provides Excellent Outcomes Throughout the Cancer Treatment Journey, from Primary Cases to Recurrence and Metastatic Disease
Innovations in Hardware and Software Solutions Reinforce the Benefits of Accuray Systems in Treating a Wide Range of Cancer Cases
CyberKnife® System Provides Effective Treatment Option with Minimal Side Effects and Excellent Cosmesis for Early Stage Breast Cancer Patients
May 02, 2017
Robotic Radiosurgery System's Unique Motion Management Technique Limits Toxicity and Preserves Cosmesis in Convenient, 5-Fraction Treatment Regimen
Accuray Names Lionel Hadjadjeba Chief Commercial Officer
April 27, 2017